Obesity is a chronic disease affecting millions of people — in 2020, the Centers for Disease Control and Prevention (CDC) reported that the overall prevalence of obesity in the United States during the period from 2017 through 2018 was 42.5%.1 The development of type 2 diabetes is a complication of obesity that leads to greater mortality primarily due to a higher incidence of cancer, cardiovascular disease, and kidney disease2 The medical effects of obesity, especially type 2 diabetes, have a greater impact on some groups — particularly Black, Hispanic, and Native Americans — than on others, adding to notable health . . .
Funding and Disclosures
Disclosure forms provided by the authors are available with the full text of this editorial at NEJM.org.
This editorial was published on June 4, 2022, at NEJM.org.
Print Subscriber? Activate your online access.